|
Re: Apropos AGM
|
2
|
Resverlogix Corp.
|
Jun 09, 2022 11:32AM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 09:26PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
2
|
Resverlogix Corp.
|
Jun 02, 2022 06:51PM
|
|
Re: BOD AGM
|
5
|
Resverlogix Corp.
|
Jun 02, 2022 08:25AM
|
|
Re: BOD AGM
|
4
|
Resverlogix Corp.
|
Jun 01, 2022 10:23AM
|
|
Re: BOD AGM
|
5
|
Resverlogix Corp.
|
Jun 01, 2022 08:00AM
|
|
Re: BOD AGM
|
4
|
Resverlogix Corp.
|
May 31, 2022 10:24PM
|
|
Re: AGM attendance
|
1
|
Resverlogix Corp.
|
May 25, 2022 05:18PM
|
|
Re: AGM attendance
|
6
|
Resverlogix Corp.
|
May 22, 2022 07:58PM
|
|
Re: great,good,bad,ugly or so so??
|
8
|
Resverlogix Corp.
|
May 19, 2022 02:34PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
6
|
Zenith Epigenetics
|
May 17, 2022 08:06AM
|
|
Re: US Covid #'s
|
3
|
Resverlogix Corp.
|
May 10, 2022 08:17AM
|
|
Re: Market Woes
|
2
|
Resverlogix Corp.
|
May 01, 2022 07:36AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 27, 2022 06:44AM
|
|
Re: New Apabetalone Fabry Disease Publication
|
7
|
Resverlogix Corp.
|
Apr 26, 2022 08:11PM
|
|
Re: Sabizabulin - mCRPC- used now for Covid 19.
|
2
|
Zenith Epigenetics
|
Apr 20, 2022 06:22PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
3
|
Resverlogix Corp.
|
Apr 19, 2022 08:35PM
|
|
Re: Resverlogix Announces One-Year Extension of Debenture
|
5
|
Resverlogix Corp.
|
Apr 19, 2022 05:30PM
|
|
Re: Exempt Distribution - 2022-04-14
|
7
|
Resverlogix Corp.
|
Apr 19, 2022 03:00PM
|
|
Re: Exempt Distribution - 2022-04-14
|
3
|
Resverlogix Corp.
|
Apr 19, 2022 11:48AM
|
